Location Cambridge, Cambridgeshire, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Female
LinkedIn View on LinkedIn
Dr Suzanne Turner is an acknowledged world expert in cancer cell biology at the University of Cambridge, UK.
She obtained her PhD in oncology from the world-renowned Paterson Institute for Cancer Research and the Christie Hospital in Manchester where she examined the potentially toxic side effects of chemoprotective gene therapy in collaboration
with AstraZeneca. Suzanne then worked at the AstraZeneca Central Toxicology Labs before moving to the Babraham Institute in Cambridge where she began to investigate mechanisms of lymphomagenesis, a subject that she has pursued to become a world-expert in paediatric lymphomas. For the past 15 years Suzanne has been leading an academic research group at the University of Cambridge with backing from various organisations with research funding of over £10m including GSK, the European Union, Bloodwise and CRUK. She also teaches aspects of the medical, veterinary and natural science tripos and runs the second-year course on the biology of disease. Suzanne has been a fellow of Hughes Hall, a Cambridge College since 2015.
In 2005, Suzanne was awarded the prestigious Leukaemia and Lymphoma Research (LLR) Bennett Fellowship and in 2010 an LLR lectureship.
Amongst her many achievements are the inception and establishment of the European Research Initiative on ALK related malignancies, the coordinator of ‘ALKATRAS’, a European Union Marie Curie innovative training network encompassing 14 research groups across 7 EU countries, the non-clinical chair of the European Inter-Group for Collaboration into Childhood Non-Hodgkin Lymphoma (EICNHL), co-chair of the Cancer Research UK (CRUK) Cambridge Centre Paediatric Programme and the biological lead for the National Cancer Research Institute (NCRI) paediatric lymphoma Clinical Study Group (CSG).
Suzanne is an invited member of the MHRA Devices Independent Expert Advisory Group; Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG) and has served as an advisor to Allergan and Cephalon Oncology. She also serves on the International grant panel of the World Cancer Research Fund.
She is an accomplished speaker having been invited to speak by the American Association for Cancer Research, the Medical University of Vienna, the Necker Institute Paris, University of Edmonton, Perelman School of Medicine Philadelphia and the University of Hail, Kingdom of Saudi Arabia among many other esteemed academic institutes.
Amongst her other interests, Suzanne is the scientific advisor to the Alex Hulme Foundation and the Francesca Richardson Research Fund. She is also a member of the American, European and British Associations for Cancer Research and the international society for paediatric oncology.
